Medication info
Sirtelmi Plus Tablet 40/12.5 mg

Sirtelmi Plus Tablet 40/12.5 mg

Prescription medicationTablet경구
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
에이치엘비제약(주)
Appearance
White or nearly white, round, biconvex tablets
Packaging
30 tablets/box [10 tablets/blister × 3]
Approval status
Active

MFDS item code 201804300 · Approved 2018.10.31 · Insurance code 647303510

Summary

Main use
Antihypertensive effect for essential hypertension
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with Telmisartan alone, this medication is taken once daily with water regardless of meals. It is recommended to adjust the individual component doses before switching to this combination product with fixed doses. - Telmisartan/Hydrochlorothiazide 40/12.5 mg is used for patients not adequately controlled with 40 mg of Telmisartan. - Telmisartan/
Child dose
The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, therefore it should not be administered.

Ingredients

Manufacturer
에이치엘비제약(주)

Efficacy & effects

Antihypertensive effect for essential hypertension

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with Telmisartan alone. It effectively lowers blood pressure to aid in hypertension management and contributes to reducing the risk of cardiovascular disease. It helps to safely and appropriately control blood pressure according to the patient's condition.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with Telmisartan alone, this medication is taken once daily with water regardless of meals. It is recommended to adjust the individual component doses before switching to this combination product with fixed doses. - Telmisartan/Hydrochlorothiazide 40/12.5 mg is used for patients not adequately controlled with 40 mg of Telmisartan. - Telmisartan/

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, therefore it should not be administered.

Precautions

This medication can pose serious risks to the fetus when taken during pregnancy, particularly in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be given to patients who are allergic to the active ingredients or excipients or have certain liver or kidney diseases. Caution should be exercised when used in the elderly or patients with specific heart conditions or weakened liver or kidney function, and regular monitoring of blood pressure, kidney function, and electrolyte levels should be conducted during treatment. The Hydrochlorothiazide component may cause electrolyte imbalance, so serum potassium, sodium, and magnesium levels should be frequently checked. Reduce exposure to sunlight or ultraviolet light during treatment, and consult a healthcare professional immediately if any skin abnormalities occur. Interactions with specific drugs may occur, so it is essential to inform your doctor or pharmacist if you are taking other medications. Dizziness or drowsiness may occur while driving or operating machinery, so caution is advised. Overdosage may lead to hypotension, electrolyte imbalance, and dehydration; if suspected, seek immediate medical attention. This medication is not recommended for individuals under 18 years of age, and in the elderly, its blood pressure-lowering effects should be closely monitored.

Side effects and when to seek care immediately

Serious side effects

Urticaria, angioedema, angioedema (including fatal outcomes), anaphylactic reaction, jaundice, acute renal failure, severe edema, acute respiratory distress syndrome (ARDS), renal function impairment

Mild side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disturbances
Show 25 more
  • dizziness
  • visual disturbances
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • distension
  • abdominal pain
  • constipation
  • indigestion
  • vomiting
  • liver dysfunction/hepatic impairment
  • erythema
  • pruritus
  • rash
  • sweating
  • back pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is vital to maintain a storage temperature between 1 degree and 30 degrees Celsius to ensure the medication's efficacy is safely preserved.

Appearance and packaging

Appearance

White or nearly white, round, biconvex tablets

Package unit

30 tablets/box [10 tablets/blister × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.